Bio-Techne jumps after Merck KGaA strikes $11.3B buyout deal

Bio-Techne jumps after Merck KGaA strikes $11.3B buyout deal
11.42BUSD
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US09073M1045
CUSIP
878377100
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
June
IPO date
-
Updated At
-
PE Ratio
66.67
PEG Ratio
2.17
Book Value
13.79
Dividend Share
0.24
Dividend Yield
0.33%
Earnings Share
1.09
Wall Street Target Price
70.50
EPS Estimate Current Year
2.04
EPS Estimate Next Year
1.70
EPS Estimate Current Quarter
0.4476
EPS Estimate Next Quarter
0.4814
Most Recent Quarter
-
Revenue TTM
1,228,195,968
Gross Profit TTM
812,713,984
EBITDA
325,379,008
Profit Margin
14.00%
Return On Assets TTM
6.45%
Return On Equity TTM
8.33%
Revenue Per Share TTM
7.858
Qtly Revenue Growth YOY
4.60%
Diluted Eps TTM
1.09
Qtly Earnings Growth YOY
-25.00%
Trailing PE
66.67
Forward PE
35
Price Sales TTM
9.2948
Price Book MRQ
5.2712
Enterprise Value Revenue
9
Enterprise Value EBITDA
34
965.00
0.00%128.26
0.00%390.94
-2.36%151.52
-2.31%925.70
-1.93%32.39
-1.88%318.32
-1.17%516.11
-1.04%917.00
-0.91%199.30
-0.11%